Nexalin Technology Files Q1 2025 10-Q
Ticker: NXL · Form: 10-Q · Filed: May 13, 2025 · CIK: 1527352
| Field | Detail |
|---|---|
| Company | Nexalin Technology, INC. (NXL) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Nexalin Tech's Q1 2025 10-Q is in, showing updated financials for stock and capital accounts.
AI Summary
Nexalin Technology, Inc. filed its 10-Q for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025 and comparative periods. Key financial statement items like common stock, additional paid-in capital, and retained earnings are presented for various dates, including March 31, 2025, December 31, 2024, and March 31, 2024.
Why It Matters
This filing provides investors with the latest financial snapshot of Nexalin Technology, Inc., crucial for understanding the company's performance and financial health in early 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information without immediate red flags.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial data)
- March 31, 2025 — Balance Sheet Date (Key date for financial position reporting)
- December 31, 2024 — Previous Year-End Date (Comparative balance sheet data)
Key Players & Entities
- Nexalin Technology, Inc. (company) — Filer of the 10-Q
- 0001527352 (company) — Central Index Key for Nexalin Technology, Inc.
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides Nexalin Technology, Inc.'s quarterly financial statements and disclosures for the period ending March 31, 2025.
What specific financial periods are covered by the comparative data in this filing?
The filing includes comparative data for the period ending March 31, 2025, and also presents data as of December 31, 2024, and March 31, 2024.
What are some of the key balance sheet accounts reported?
Key balance sheet accounts reported include Common Stock, Accumulated Other Comprehensive Income, Additional Paid-In Capital, and Retained Earnings.
What is Nexalin Technology, Inc.'s Standard Industrial Classification (SIC) code?
Nexalin Technology, Inc.'s SIC code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 13, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Nexalin Technology, Inc. (NXL).